EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z guide NIH and FDA sources Human studies

Supplement interactions

Documented interactions of supplements with medicines, with each other and with food, in tables you can filter. Each row links to the NIH, FDA or peer-reviewed source it was taken from.

79documented interactions in the tables below, each with its source
−79.4%oral midazolam exposure after 14 days of a St. John's wort extract with 41 mg/day hyperforin
≈25%fall in metformin levels in healthy adults given goldenseal extract
15business days for a supplement company to report a serious adverse event to FDA

Mueller et al., Eur J Clin Pharmacol 2006; NCCIH, Goldenseal (February 2025); 21 U.S.C. 379aa-1.

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Do not start, stop or change the timing of a medicine because of this page; tell your doctor or pharmacist about every supplement you take. An interaction missing here may still exist.

Related: Supplements A–Z · How to judge a supplement · ADME, PK and PBPK · Combination science

Schematic, Mixing changes what each ingredient does: One supplement ingredient What happens when it meets something else? Another supplement Vitamin C raises the uptake of iron from plant foods and supplements Can help A medicine St. John’s wort cut midazolam exposure by 79.4% after 14 days Can weaken a medicine A blood thinner Ginkgo, garlic, vitamin E and fish oil are documented with bleeding risk Can add risk Alcohol Kava with alcohol: liver damage and drowsiness; valerian: more drowsiness Can add harm Food Phytate in grains and beans lowers iron and zinc uptake Can block Documented examples; sources are listed on this page. Ask a pharmacist before combining supplements with medicines.
Schematic Documented examples from the tables below, drawn by EUTECNIQ. No flag here means a combination is safe; ask a pharmacist.

Filter the interaction tables

A pair missing from these tables is not a pair known to be safe. The tables hold 79 documented interactions from the sources cited; many combinations have never been studied. Ask a pharmacist or physician about any supplement taken with a medicine.

Overview

Where interactions happen

An interaction is a change in the effect of a medicine or nutrient caused by something taken with it. The rows below act in four places. In the gut, minerals bind drugs or change absorption. In the gut wall and liver, enzymes and transporters clear drugs. Other pairs act on the same body system, or in the kidney.

A row names the mechanism only when its source states one. “Mechanism not stated by the source” means the interaction is documented, not explained.

44 of 79 documented interactions change absorption, metabolism or transport; 7 act on the same body systemExamples from the tables below
Four places where documented supplement interactions act: gut contents, gut wall and liver, blood and tissues, kidney1 · Binding and absorptionGut contentsCalcium, magnesium, ironand zinc lower absorptionof some antibiotics,levothyroxine,bisphosphonates,dolutegravir or levodopa.Phytate lowers iron andzinc uptake; vitamin Craises nonheme ironuptake. Orlistat, PPIs,metformin andsulfasalazine lower uptakeof some vitamins.2 · Enzymes and transportersGut wall and liverSt. John's wort inducesCYP enzymes andP-glycoprotein, so lessdrug reaches the blood.Goldenseal and grapefruitjuice inhibit CYP3A, somore reaches it. Grapefruitjuice also acts ontransporters (lessfexofenadine).3 · Same body systemBlood and tissuesVitamin K opposeswarfarin. Ginkgo, garlic,vitamin E and fish oil aredocumented with bleedingrisk alongsideanticoagulants. St. John'swort can add to the effectsof drugs that act onserotonin. Retinoids takenwith vitamin A raise the riskof hypervitaminosis A.4 · ExcretionKidneyACE inhibitors, ARBs andpotassium-sparing diureticskeep potassium in(hyperkalemia). Loop andthiazide diuretics raisepotassium and magnesiumloss. Cycloserine raisesvitamin B6 loss.Four places where documented supplement interactions act: gut contents, gut wall and liver, blood and tissues, kidney1 · Binding and absorptionGut contentsCalcium, magnesium, iron and zinc lower absorptionof some antibiotics, levothyroxine, bisphosphonates,dolutegravir or levodopa. Phytate lowers iron andzinc uptake; vitamin C raises nonheme iron uptake.Orlistat, PPIs, metformin and sulfasalazine loweruptake of some vitamins.2 · Enzymes and transportersGut wall and liverSt. John's wort induces CYP enzymes andP-glycoprotein, so less drug reaches the blood.Goldenseal and grapefruit juice inhibit CYP3A, somore reaches it. Grapefruit juice also acts ontransporters (less fexofenadine).3 · Same body systemBlood and tissuesVitamin K opposes warfarin. Ginkgo, garlic, vitamin Eand fish oil are documented with bleeding riskalongside anticoagulants. St. John's wort can add tothe effects of drugs that act on serotonin. Retinoidstaken with vitamin A raise the risk ofhypervitaminosis A.4 · ExcretionKidneyACE inhibitors, ARBs and potassium-sparingdiuretics keep potassium in (hyperkalemia). Loopand thiazide diuretics raise potassium andmagnesium loss. Cycloserine raises vitamin B6 loss.
Each example is a row in the tables on this page, with its NIH, FDA or peer-reviewed source. Schematic, not to scale; the four places are a reading aid, not a classification used by FDA or NIH.
Herbs and medicines

Herbs with medicines

St. John's wort has the longest documented list. NCCIH says it “can weaken the effects of many medicines” and calls it a potent inducer of cytochrome P450 enzymes and intestinal P-glycoprotein; how strongly it induces depends on the product's hyperforin content. Goldenseal works the other way at CYP3A and raises exposure.

For ginkgo and garlic the documented concern is bleeding with anticoagulants. The pharmacokinetic studies are discussed in ADME, PK and PBPK.

Documented interactions between herbal supplements and medicines
SupplementWithWhat happensWhat the source advises or addsSource
St. John's wortSome antidepressants, including amitriptyline and bupropionCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortBirth control pillsCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortCyclosporine (prevents rejection of transplanted organs)Can weaken the effect; NCCIH calls the interaction clinically significant.Metabolism or transportNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortSeizure medicines phenytoin and carbamazepineCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort
St. John's wortHeart medicines digoxin and ivabradineCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortHIV medicines indinavir and nevirapineCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortCancer medicines irinotecan, imatinib and docetaxelCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort
St. John's wortWarfarin (anticoagulant)Can weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortCertain statins, including simvastatinCan weaken the effect of the medicine.Metabolism or transportNCCIH St. John's wort
St. John's wortAntidepressants or other drugs that affect serotoninMay increase serotonin-related side effects, which can be serious.Same body systemNCCIH St. John's wort NCCIH herb–drug digest
St. John's wortMidazolam (test drug for the CYP3A enzyme)14 days in 42 healthy men: oral midazolam AUC0–12 h fell 79.4%, 47.9% and 21.1% with products giving 41, 12 and 0.13 mg/day hyperforin.Metabolism or transportFDA lists St. John's wort as a strong CYP3A inducer and notes that its effect “varies widely and is preparation dependent.”Mueller 2006 FDA interaction table
GoldensealMetformin (diabetes medicine)Metformin levels fell about 25% in healthy adults given goldenseal extract.Mechanism not stated by the sourceNCCIH: enough to potentially hinder glucose control in people with type 2 diabetes taking metformin. A 2025 crossover study in adults with type 2 diabetes found no clinically meaningful interaction overall (metformin AUC ratio 0.93), with about a 20% fall at low metformin doses (Nguyen 2025, Clin Transl Sci 18:e70120).NCCIH goldenseal NCCIH herb–drug digest
GoldensealMedicines processed by the enzymes CYP2D6 and CYP3A4Goldenseal has been shown to inhibit both enzymes.Metabolism or transportNCCIH herb–drug digest
GoldensealMidazolam (test drug for the CYP3A enzyme)Oral midazolam AUC ratio 1.43 (90% CI 1.35–1.53); in a second study AUC and Cmax rose 40–60%, mainly by intestinal CYP3A inhibition.Metabolism or transportIntravenous midazolam AUC ratio 0.97: no systemic effect.Nguyen 2021 Nguyen 2023
GinkgoWarfarin (anticoagulant)Associated with an increased risk of major bleeding events compared with warfarin alone.Mechanism not stated by the sourceNCCIH herb–drug digest NCCIH ginkgo
GinkgoEfavirenz (HIV medicine)Using ginkgo preparations with efavirenz is not recommended.Mechanism not stated by the sourceNCCIH herb–drug digest
GarlicAnticoagulants or aspirinGarlic supplements may increase the risk of bleeding.Mechanism not stated by the sourceTell your health care providers, especially before surgery.NCCIH garlic
Green teaNadolol (beta-blocker)Green tea at high doses reduced blood levels, and therefore the effectiveness, of nadolol.Mechanism not stated by the sourceNCCIH herb–drug digest
Green tea extractAtorvastatin (statin)Can reduce blood levels of atorvastatin.Mechanism not stated by the sourceNCCIH herb–drug digest
ChamomileOral contraceptivesMight decrease the effects of oral contraceptives.Mechanism not stated by the sourceNCCIH herb–drug digest
ChamomileWarfarin and some drugs metabolized by the liverInteractions have been reported.Mechanism not stated by the sourceNCCIH notes theoretical reasons to suspect interactions with other drugs, such as sedatives.NCCIH herb–drug digest
Asian ginsengWarfarin (anticoagulant)Studies have had mixed results.Mechanism not stated by the sourceInteractions with calcium channel blockers, other blood pressure medicines, statins and some antidepressants are uncertain.NCCIH herb–drug digest
CranberryWarfarin (anticoagulant)Evidence on whether cranberry interacts with warfarin is conflicting.Mechanism not stated by the sourceNCCIH herb–drug digest
Cat's clawAnticoagulant and antiplatelet drugs, blood pressure drugs, calcium channel blockers, CYP3A4 substrates, immunosuppressantsMay interact; NCCIH describes these interactions as theoretical.Mechanism not stated by the sourceNCCIH herb–drug digest
Licorice rootCorticosteroidsInteractions have been reported.Mechanism not stated by the sourceGlycyrrhizin in licorice can cause irregular heartbeat and cardiac arrest, especially in large amounts or long-term use.NCCIH licorice root
Vitamins and minerals

Vitamins and minerals with medicines

Minerals act mostly in the gut: calcium, magnesium, iron and zinc lower the absorption of some antibiotics, levothyroxine, bisphosphonates, dolutegravir and levodopa. Common medicines also lower nutrients: proton pump inhibitors (vitamin B12, iron, magnesium), metformin (B12), orlistat (vitamins A, D and K) and diuretics (magnesium, potassium, zinc).

Documented interactions between vitamin or mineral supplements and medicines
SupplementWithWhat happensWhat the source advises or addsSource
Vitamin KWarfarin and similar anticoagulants (phenprocoumon, acenocoumarol, tioclomarol)A serious and potentially dangerous interaction: these drugs work by antagonizing vitamin K.Same body systemKeep vitamin K intake consistent; sudden changes can strengthen or weaken the anticoagulant effect.ODS vitamin K
Vitamin KAntibiotics, especially cephalosporinsMay lower vitamin K status by killing vitamin K-producing gut bacteria.Nutrient statusSupplements are usually unnecessary unless use lasts several weeks or more and intake is poor.ODS vitamin K
Vitamin KBile acid sequestrants (cholestyramine, colestipol)Can reduce absorption of vitamin K and other fat-soluble vitamins; clinical significance unclear.AbsorptionODS vitamin K
Vitamin KOrlistatReduces absorption of fat-soluble vitamins; with warfarin it may significantly increase prothrombin time.AbsorptionODS vitamin K
Vitamin AOrlistatCan decrease absorption of vitamin A, other fat-soluble vitamins and beta-carotene.AbsorptionODS vitamin A
Vitamin ARetinoids (acitretin, bexarotene)Can increase the risk of hypervitaminosis A when taken with vitamin A supplements.Same body systemODS vitamin A
Vitamin DOrlistatCan reduce absorption of vitamin D from food and supplements, lowering 25(OH)D levels.AbsorptionODS vitamin D
Vitamin DStatins (atorvastatin, lovastatin, simvastatin)Statins may reduce vitamin D synthesis; high vitamin D intakes might reduce the potency of these statins, which appear to compete for the same metabolizing enzyme.Metabolism or transportODS vitamin D
Vitamin EAnticoagulant and antiplatelet medicinesVitamin E can inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors; large doses can increase bleeding risk.Same body systemODS vitamin E
Vitamin E and other antioxidantsSimvastatin with niacinAntioxidant ingredients blunted the rise in HDL cholesterol.Mechanism not stated by the sourceODS vitamin E
Vitamin E, vitamin C and other antioxidantsCancer chemotherapy or radiotherapyMight reduce the effectiveness of these therapies; oncologists generally advise against antioxidant supplements during treatment.Mechanism not stated by the sourceConsult the oncologist before taking vitamin C or other antioxidant supplements.ODS vitamin E ODS vitamin C
Vitamin CStatinsHealth care providers should monitor lipid levels in people taking statins and antioxidant supplements.Mechanism not stated by the sourceODS vitamin C
Vitamin B6Cycloserine (tuberculosis medicine)Increases urinary excretion of pyridoxine, which may worsen the drug's seizure and neurotoxicity risks.ExcretionPyridoxine supplements can help prevent these effects.ODS vitamin B6
Vitamin B6Antiepileptics (valproic acid, carbamazepine, phenytoin)These drugs speed vitamin B6 breakdown and lower plasma PLP; pyridoxine 200 mg/day for 12–120 days can reduce serum phenytoin and phenobarbital.Metabolism or transportODS vitamin B6
Vitamin B6TheophyllinePatients treated with theophylline often have low plasma PLP concentrations.Nutrient statusODS vitamin B6
Folate (folic acid)MethotrexatePeople taking methotrexate for cancer should consult their oncologist first; folate might reduce gastrointestinal side effects of low-dose methotrexate.Mechanism not stated by the sourceODS folate
Folate (folic acid)Antiepileptic medicinesThese medicines can reduce serum folate; folate supplements might reduce serum levels of the medicines.Nutrient statusODS folate
Folate (folic acid)SulfasalazineInhibits intestinal absorption of folate and can cause folate deficiency.AbsorptionODS folate
Vitamin B12Proton pump inhibitors (omeprazole, lansoprazole) and H2 blockers (cimetidine, ranitidine)Can interfere with B12 absorption from food by slowing the release of gastric acid, and can lead to deficiency.AbsorptionODS vitamin B12
Vitamin B12MetforminMight reduce B12 absorption and significantly reduce serum B12 concentrations.AbsorptionODS vitamin B12
CalciumDolutegravir (HIV medicine)Can substantially lower dolutegravir blood levels, apparently through chelation.AbsorptionLabels advise dolutegravir 2 hours before or 6 hours after calcium supplements.ODS calcium
CalciumLevothyroxineCalcium carbonate can impair levothyroxine absorption.AbsorptionThe label advises against levothyroxine within 4 hours of the supplement.ODS calcium
CalciumLithiumLong-term lithium can cause hypercalcemia; calcium supplements may raise that risk.Same body systemODS calcium
CalciumQuinolone antibiotics (ciprofloxacin, gemifloxacin, moxifloxacin)Calcium can reduce absorption of these antibiotics.AbsorptionTaking the antibiotic 2 hours before or 2 hours after calcium prevents this effect.ODS calcium
MagnesiumOral bisphosphonates (alendronate)Magnesium-rich supplements or medicines can decrease bisphosphonate absorption.AbsorptionSeparate them by at least 2 hours.ODS magnesium
MagnesiumTetracyclines (demeclocycline, doxycycline) and quinolones (ciprofloxacin, levofloxacin)Magnesium can form insoluble complexes with these antibiotics.AbsorptionTake the antibiotic at least 2 hours before or 4–6 hours after magnesium.ODS magnesium
MagnesiumLoop diuretics (furosemide, bumetanide, ethacrynic acid) and thiazide diuretics (hydrochlorothiazide)Chronic use can increase urinary magnesium loss and lead to depletion; potassium-sparing diuretics (amiloride, spironolactone) reduce magnesium excretion.ExcretionODS magnesium
MagnesiumProton pump inhibitors (esomeprazole, lansoprazole)Can cause hypomagnesemia when taken for prolonged periods (typically more than a year); in 25% of cases FDA reviewed, supplements did not raise magnesium and the PPI had to be stopped.Nutrient statusODS magnesium
IronLevodopaIron supplements reduce levodopa absorption in healthy people, possibly through chelation.AbsorptionODS iron
IronLevothyroxineCan significantly reduce levothyroxine efficacy in some patients.AbsorptionSome labels advise against levothyroxine within 4 hours of iron supplements.ODS iron
IronProton pump inhibitorsLower stomach acidity can reduce nonheme iron absorption; patients with iron deficiency can respond poorly to iron supplements.AbsorptionODS iron
ZincQuinolone and tetracycline antibioticsZinc may interact with these antibiotics.AbsorptionTaking the antibiotic at least 2 hours before or 4–6 hours after zinc minimizes the interaction.ODS zinc
ZincPenicillamineZinc may interact with penicillamine.AbsorptionTake zinc and penicillamine at least 1 hour apart.ODS zinc
ZincSome diureticsCan decrease serum zinc by increasing zinc excretion in urine.ExcretionODS zinc
PotassiumACE inhibitors and angiotensin receptor blockersReduce urinary potassium excretion, which can lead to hyperkalemia.ExcretionExperts recommend monitoring potassium status.ODS potassium
PotassiumPotassium-sparing diureticsReduce urinary potassium excretion and can cause hyperkalemia.ExcretionExperts recommend monitoring potassium status.ODS potassium
PotassiumLoop and thiazide diureticsIncrease urinary potassium excretion and can lead to hypokalemia.ExcretionExperts recommend monitoring and supplementation if warranted.ODS potassium
Omega-3 (fish oil)WarfarinFish oil might prolong clotting time (higher INR); most research finds 3–6 g/day does not significantly affect anticoagulant status.Same body systemLabels of FDA-approved omega-3 drugs advise periodic INR monitoring in patients on anticoagulants.ODS omega-3
Timing

Spacing doses apart

For the gut interactions, NIH fact sheets give separation times. They range from 1 hour (zinc and penicillamine) to 6 hours (dolutegravir after calcium). The label and the pharmacist give the instruction for a specific product; these are the values the fact sheets report.

Separation times range from 1 hour to 6 hours, and some windows are longer after the supplement than before itNIH ODS fact sheets
Hours to keep between doses for eight mineral–medicine pairs, as NIH Office of Dietary Supplements fact sheets state themsupplement dosemedicine earliermedicine laterQuinolone antibiotics + calcium2 h before or 2 h afterQuinolone antibiotics + calcium: 2 h before or 2 h afterDolutegravir + calcium2 h before or 6 h afterDolutegravir + calcium: 2 h before or 6 h afterLevothyroxine + calcium carbonatenot within 4 hLevothyroxine + calcium carbonate: not within 4 hOral bisphosphonates + magnesiumat least 2 h apartOral bisphosphonates + magnesium: at least 2 h apartTetracyclines, quinolones + magnesium≥2 h before or 4–6 h afterTetracyclines, quinolones + magnesium: ≥2 h before or 4–6 h afterTetracyclines, quinolones + magnesium: upper end of the 4–6 h rangeLevothyroxine + ironnot within 4 h (labels)Levothyroxine + iron: not within 4 h (labels)Quinolones, tetracyclines + zinc≥2 h before or 4–6 h afterQuinolones, tetracyclines + zinc: ≥2 h before or 4–6 h afterQuinolones, tetracyclines + zinc: upper end of the 4–6 h rangePenicillamine + zincat least 1 h apartPenicillamine + zinc: at least 1 h apart-6 h-4 h-2 h0+2 h+4 h+6 hMedicine dose time relative to the supplementkeep the medicine out of this windowend of a range given as 4–6 hHours to keep between doses for eight mineral–medicine pairs, as NIH Office of Dietary Supplements fact sheets state themsupplement dosemedicine earliermedicine laterQuinolone antibiotics + calcium2 h before or 2 h afterQuinolone antibiotics + calcium: 2 h before or 2 h afterDolutegravir + calcium2 h before or 6 h afterDolutegravir + calcium: 2 h before or 6 h afterLevothyroxine + calcium carbonatenot within 4 hLevothyroxine + calcium carbonate: not within 4 hOral bisphosphonates + magnesiumat least 2 h apartOral bisphosphonates + magnesium: at least 2 h apartTetracyclines, quinolones + magnesium≥2 h before or 4–6 h afterTetracyclines, quinolones + magnesium: ≥2 h before or 4–6 h afterTetracyclines, quinolones + magnesium: upper end of the 4–6 h rangeLevothyroxine + ironnot within 4 h (labels)Levothyroxine + iron: not within 4 h (labels)Quinolones, tetracyclines + zinc≥2 h before or 4–6 h afterQuinolones, tetracyclines + zinc: ≥2 h before or 4–6 h afterQuinolones, tetracyclines + zinc: upper end of the 4–6 h rangePenicillamine + zincat least 1 h apartPenicillamine + zinc: at least 1 h apart-6 h-4 h-2 h0+2 h+4 h+6 hMedicine dose time relative to the supplementkeep the medicine out of this window
NIH Office of Dietary Supplements fact sheets for health professionals: calcium (page modified October 27, 2026), magnesium and zinc (updated January 6, 2026), iron (updated September 4, 2025). Bars span the times the sources say to avoid; the levothyroxine–iron window is the advice of some product labels as ODS reports it.
Show data: spacing as each source words it
Dose spacing for mineral supplements and medicines, as NIH ODS states it
MedicineSupplementSpacing the source givesSource
Quinolone antibioticsCalcium2 h before or 2 h after calciumODS calcium
DolutegravirCalcium2 h before or 6 h after calciumODS calcium
LevothyroxineCalcium carbonateNot within 4 h of the supplementODS calcium
Oral bisphosphonatesMagnesiumAt least 2 h apartODS magnesium
Tetracyclines or quinolonesMagnesiumAt least 2 h before or 4–6 h after magnesiumODS magnesium
LevothyroxineIronNot within 4 h of iron (some labels)ODS iron
Quinolones or tetracyclinesZincAt least 2 h before or 4–6 h after zincODS zinc
PenicillamineZincAt least 1 h apartODS zinc
Nutrients together

Nutrients with each other

Six documented pairs change absorption: vitamin C and meat raise nonheme iron absorption, vitamin D raises calcium absorption, iron at 25 mg or more lowers zinc absorption, zinc at 50 mg/day or more for weeks can inhibit copper absorption, and calcium might lower iron absorption. Large amounts of folate can correct the anemia of vitamin B12 deficiency but not its neurological damage.

Documented interactions between nutrients
Nutrient or foodWithEffectWhat happensNote from the sourceSource
Vitamin CNonheme iron (iron from plant foods)RaisesVitamin C improves absorption of nonheme iron.AbsorptionLow vitamin C intake can decrease nonheme iron absorption.ODS vitamin C ODS iron
Meat, poultry and seafoodNonheme ironRaisesEnhance nonheme iron absorption.AbsorptionODS iron
Vitamin DCalciumRaisesVitamin D promotes calcium absorption in the gut and is required for absorption by active transport.AbsorptionODS vitamin D ODS calcium
CalciumIron (heme and nonheme)LowersCalcium might reduce the bioavailability of both forms; the effect has not been definitively established.AbsorptionODS iron
Iron, 25 mg or moreZinc taken at the same timeLowersCan reduce zinc absorption and plasma zinc concentrations.AbsorptionIron added to enriched or fortified foods does not significantly interfere with zinc absorption.ODS zinc
Zinc, 50 mg/day or more for weeksCopperLowersCan inhibit copper absorption; chronic excess can cause copper deficiency.AbsorptionThe adult zinc UL, 40 mg/day, is based on the adverse effect of zinc on copper status.ODS zinc
Folate, large amountsVitamin B12 deficiencyMasksCan correct the megaloblastic anemia of B12 deficiency but not its neurological damage.Nutrient statusODS notes that concern has shifted to large amounts of folate precipitating or worsening the anemia and cognitive symptoms of vitamin B12 deficiency.ODS folate
Vitamin E, large dosesLow vitamin K intakeAdds riskLarge doses can increase bleeding risk, especially with low vitamin K intake.Same body systemODS vitamin E
Plant compounds

Plant compounds with nutrients

Phytate and some polyphenols in grains, beans and legumes lower iron and zinc absorption. The most quoted pairing, piperine with curcumin, is most often traced to a small 1998 study in which curcumin alone was mostly undetectable, so its 2000% compares against a baseline near zero.

Higher curcumin exposure also carries a documented safety risk. NCCIH says highly bioavailable formulations may harm the liver, and NIH LiverTox links such products to cases of liver injury.

Documented interactions of plant compounds with nutrients and with each other
Plant compoundWithEffectWhat happensNote from the sourceSource
Phytate (grains and beans)Nonheme ironLowersPhytate inhibits nonheme iron absorption.AbsorptionODS iron
Phytate (legumes and whole grains)ZincLowersPhytate binds zinc in the intestine and forms an insoluble complex that inhibits its absorption.AbsorptionODS zinc
Polyphenols in some plant foods (cereals, legumes)Nonheme ironLowersCertain polyphenols inhibit nonheme iron absorption.AbsorptionIn a typical Western diet the effects of these enhancers and inhibitors are attenuated.ODS iron
Piperine (black pepper), 20 mgCurcumin, 2 gRaisesIn ten healthy men, serum curcumin was undetectable or very low after curcumin alone; with piperine “the increase in bioavailability was 2000%.”AbsorptionThe 2000% is relative to a baseline mostly below detection; it measures serum curcumin, not an effect.Shoba 1998
High-bioavailability curcumin products, some with piperineThe liverSafety signalHighly bioavailable curcumin formulations “may harm your liver”; LiverTox links such products to cases of liver injury.Mechanism not stated by the sourceLiverTox: HLA-B*35:01 in over 70% of turmeric liver-injury cases versus 10–15% of controls.NCCIH turmeric LiverTox turmeric
Food and medicines

Foods with medicines

FDA warns that grapefruit juice raises the blood levels of some medicines and lowers others, and that Seville oranges, pomelos and tangelos might act the same way. For warfarin, NIH advises a consistent vitamin K intake from food and supplements rather than sudden changes (vitamin K row above).

Documented food–medicine interactions from FDA
FoodWithDirectionWhat happensNote from the sourceSource
Grapefruit juiceSome statins (simvastatin, atorvastatin), nifedipine, cyclosporine, buspirone, budesonide, amiodaroneRaises drug levelMore of the drug enters the blood and stays in the body longer (intestinal enzyme CYP3A4).Metabolism or transportFDA lists grapefruit juice as a moderate CYP3A inhibitor whose effect varies with brand, concentration, dose and preparation.FDA grapefruit juice FDA interaction table
Grapefruit juiceFexofenadine (antihistamine)Lowers drug levelGrapefruit juice affects drug transporters, so less drug can reach the blood.Metabolism or transportFexofenadine may also not work as well with orange or apple juice.FDA grapefruit juice
Seville oranges, pomelos, tangelosThe same medicines as grapefruit juiceMay act like grapefruitMight have the same effect as grapefruit juice.Metabolism or transportFDA grapefruit juice
Combinations

What “synergistic” requires

Each combination above that increases a level (vitamin C or meat with nonheme iron, vitamin D with calcium, piperine with curcumin) acts on absorption. None of them was measured as synergy. In pharmacology, synergy means a combined effect larger than a named reference model predicts from each ingredient alone.

A label that calls a product “synergistic” therefore needs dose–response data for each ingredient alone and together, the model named, and confidence intervals; a claim about people needs a human trial built to test the interaction (combination science).

Terms used for combinations, what each means and the data each needs
TermMeaningData needed
Pharmacokinetic enhancementOne ingredient raises the blood level of another (piperine with curcumin; vitamin C with nonheme iron)Blood levels or absorption with and without the partner; says nothing about effect
Additivity (Loewe)Each ingredient acts as a dilution of the other: dA/DA + dB/DB = 1 at a chosen effect levelDose–response curves of each alone and of the mixture
Bliss independenceIngredients act independently: expected effect EA + EB − EA·EB (effects as fractions of maximum)Effects of each alone and together at the same doses
Highest single agentExpected effect is the larger of the two single effectsSame as Bliss
Synergy, antagonismObserved effect above, or below, the reference model's expectation; the Saariselkä agreement asks authors to write “Loewe synergy” or “Bliss synergy”Replicated measurements with confidence intervals, model stated
Combination index (Chou–Talalay)CI = dA/DA + dB/DB, from median-effect fits; CI < 1 synergism, CI = 1 additive, CI > 1 antagonismDose–effect data for each agent and the mixture; CI is reported per effect level
IsobologramPlot of the dose pairs giving one effect level; the Loewe line joins the two single-agent dosesDoses of each alone, and of mixtures, that reach that effect level

Tang J, Wennerberg K, Aittokallio T. Front Pharmacol 2015;6:181; Chou TC. Cancer Res 2010;70:440–446. DA, DB: dose of each alone that gives the chosen effect; dA, dB: their doses in the mixture that give the same effect.

The figure shows why the model must be named. It takes two ingredients that act exactly independently (Bliss) and asks what Loewe additivity calls them. At 25% effect the mixture looks antagonistic (CI 1.175), at 50% still antagonistic (1.087), and at 75% synergistic (0.939), with no interaction at all.

A pair with no interaction under Bliss is called antagonistic or synergistic under Loewe, depending on the effect level and the Hill slopesComputed model
Panel A: isobologram of a pair that follows Bliss independence exactly, at 25, 50 and 75 percent effect, against the Loewe line. Panel B: the Loewe combination index of that mixture across effect levels for three pairs of Hill slopesA · Same pair, three effect levels (Hill slopes 1 and 2)00.51Dose of B ÷ dose of B alone00.51Dose of A ÷ dose of A aloneBliss-additive dose pairs at 25% effectBliss-additive dose pairs at 50% effectBliss-additive dose pairs at 75% effectLoewe line, CI = 1Bliss-independent pair at:25% effect50% effect75% effectB · Combination index of the same kind of mixture0.20.61.01.4Loewe combination index5%25%50%75%95%Effect levelCI > 1: “antagonism”CI < 1: “synergy”Hill slopes 1 and 1Hill slopes 1 and 2Hill slopes 2 and 2slopes 1 and 1slopes 1 and 2slopes 2 and 2Panel A: isobologram of a pair that follows Bliss independence exactly, at 25, 50 and 75 percent effect, against the Loewe line. Panel B: the Loewe combination index of that mixture across effect levels for three pairs of Hill slopesA · Same pair, three effect levelsHill slopes 1 and 200.51Dose of B ÷ dose of B alone00.51Dose of A ÷ dose of A aloneBliss-additive dose pairs at 25% effectBliss-additive dose pairs at 50% effectBliss-additive dose pairs at 75% effectLoewe line, CI = 1Bliss-independent pair at:25% effect50% effect75% effectB · Combination index by effect level0.20.61.01.4Loewe combination index5%25%50%75%95%Effect levelCI > 1: “antagonism”CI < 1: “synergy”Hill slopes 1 and 1Hill slopes 1 and 2Hill slopes 2 and 21 and 11 and 22 and 2Hill slopes of the two agents
Computed by EUTECNIQ: single agents E = un/(1 + un) with equal maxima; Bliss expectation EA + EB − EAEB (Tang et al. 2015); Loewe line and combination index as in Chou 2010. Panel B: mixtures with equal shares of each agent's single-agent dose. Slopes are illustrative and describe no ingredient. Interactive version: combination science.
Safety reporting

Report a problem

If a supplement may have caused harm, stop using it, get medical care if needed, and report it. Consumers report voluntarily; the company named on the label has a legal duty to forward serious reports it receives.

How and when supplement problems are reported to FDA
WhoHowRequirementSource
Consumers, caregivers and health professionalsFDA Safety Reporting Portal (“a private citizen… submitting a voluntary report”), or FDA's general line 1-888-INFO-FDA (1-888-463-6332)Voluntary; include as much information as you canFDA reporting page
Anyone, to the companyContact information on the product labelVoluntaryFDA 101
Manufacturer, packer or distributor named on the labelReport to FDA every serious adverse event report it receives (the Safety Reporting Portal can be used)Within 15 business days; new medical information within 1 year of the first report; records kept 6 years21 U.S.C. 379aa-1
What counts as seriousDeath, a life-threatening experience, inpatient hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an event needing medical or surgical intervention to prevent one of these21 U.S.C. 379aa-1
EUTECNIQ Proposed

Where EUTECNIQ would work

EUTECNIQ would screen botanical extracts against CYP3A and transporter probes and measure mineral binding before any human study, and would call a combination synergistic only with dose–response data against a named reference model. It has no laboratory, studies or data yet.

Related pages: Supplements A–Z · How to judge a supplement · ADME, PK and PBPK · Combination science · Risk assessment

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.